Management of Heparin Infusion Before Surgery
You should stop the heparin infusion at least 4 hours before surgery, not continue it up until the procedure. 1
Pre-operative Heparin Management
The 2022 American College of Chest Physicians guidelines provide clear direction for patients receiving therapeutic-dose IV unfractionated heparin (UFH) who require elective surgery 1:
Timing of Discontinuation
- Stop UFH ≥4 hours before surgery (conditional recommendation, very low certainty evidence)
- UFH has a dose-dependent elimination half-life of approximately 90 minutes (range 30-120 minutes) 1
- Stopping 4-6 hours pre-operatively eliminates residual anticoagulant effect based on pharmacokinetics 1
Critical point: The question of whether to "continue" heparin is actually asking about timing—you must discontinue it, but the key is doing so at the appropriate interval to allow anticoagulant effects to dissipate while minimizing thrombotic risk.
Post-operative Resumption
After surgery, the guidelines recommend 1:
- Resume UFH ≥24 hours after surgery for low-to-moderate bleed-risk procedures
- Wait 48-72 hours for high-bleed-risk surgeries
- When resuming, avoid bolus dosing and start with a lower-intensity infusion than pre-operative rates
- Use a lower target aPTT than standard full-dose UFH initiation 1
Clinical Context Matters
The decision to use heparin bridging at all depends on the patient's thrombotic risk 2:
High-Risk Patients (Consider Bridging)
- Mechanical mitral valve or older-generation valves
- Recent stroke/TIA (<3 months)
- Recent VTE (<3 months)
- CHA₂DS₂-VASc score ≥7
Low-to-Moderate Risk (Generally No Bridging)
- Bileaflet aortic valve without major stroke risk factors
- VTE >12 months ago
- Atrial fibrillation with CHA₂DS₂-VASc 1-4
Important caveat: The evidence supporting heparin bridging itself is weak. The 2022 guidelines suggest against bridging for most low-to-moderate risk patients, as bridging increases bleeding risk without clear thrombotic benefit 3.
Practical Algorithm
- Assess thrombotic risk using validated criteria (mechanical valve type, stroke history, VTE timing)
- If bridging is indicated:
- Stop UFH 4-6 hours before surgery 1
- Document last infusion time and verify aPTT normalization if time permits
- Post-operatively:
Common Pitfalls
- Don't continue heparin too close to surgery: Stopping <4 hours before increases bleeding risk without adequate time for anticoagulant reversal
- Don't rush post-operative resumption: Starting <24 hours significantly increases major bleeding, particularly after high-risk procedures (up to 20% in some studies) 1
- Don't automatically bridge all anticoagulated patients: Many patients at low-moderate thrombotic risk have better outcomes without bridging 3
The FDA labeling confirms UFH should be stopped 4-6 hours pre-operatively when used for bridging anticoagulation 4, aligning with guideline recommendations.